Matches in Wikidata for { <http://www.wikidata.org/entity/Q66036902> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66036902 description "clinical trial" @default.
- Q66036902 description "ensayu clínicu" @default.
- Q66036902 description "klinisch onderzoek" @default.
- Q66036902 description "клінічне випробування" @default.
- Q66036902 name "Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery" @default.
- Q66036902 name "Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery" @default.
- Q66036902 type Item @default.
- Q66036902 label "Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery" @default.
- Q66036902 label "Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery" @default.
- Q66036902 prefLabel "Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery" @default.
- Q66036902 prefLabel "Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery" @default.
- Q66036902 P1050 Q66036902-D6CF029B-A523-40BF-9DE0-0898247D88D2 @default.
- Q66036902 P1132 Q66036902-7F12A500-F157-472F-B597-C6ACBF31812D @default.
- Q66036902 P1476 Q66036902-2C18C97F-77B7-41CD-B015-91F703542782 @default.
- Q66036902 P17 Q66036902-F64CDE9A-95C3-4BEA-8B8D-E7F014E64746 @default.
- Q66036902 P3098 Q66036902-A0459C83-FE47-44D5-B14C-C58CAC9E1CCD @default.
- Q66036902 P31 Q66036902-A7599F7B-3051-4FE0-BB1A-CB6F7CC89D4D @default.
- Q66036902 P4844 Q66036902-92BE45DA-C44A-4DC7-A795-CA10712AE69B @default.
- Q66036902 P4844 Q66036902-E5D1BE3A-7125-44A6-B6B9-217B8936EB06 @default.
- Q66036902 P580 Q66036902-B41F5499-3DB2-4A67-8F79-237EFC2273CB @default.
- Q66036902 P582 Q66036902-6FFFEC74-D179-4FC8-B622-4321F31EC077 @default.
- Q66036902 P6099 Q66036902-0D32D830-9DF0-4529-B71D-5AD5972216B5 @default.
- Q66036902 P8363 Q66036902-156D874F-B22C-4045-9BC0-2E2203BD2174 @default.
- Q66036902 P1050 Q356033 @default.
- Q66036902 P1132 "+840" @default.
- Q66036902 P1476 "A Phase III Trial of Cisplatin/Etoposide/Radiotherapy With Consolidation Docetaxel Followed by Maintenance Therapy With ZD1839 (NSC-715055) or Placebo in Patients With Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer" @default.
- Q66036902 P17 Q30 @default.
- Q66036902 P3098 "NCT00020709" @default.
- Q66036902 P31 Q30612 @default.
- Q66036902 P4844 Q27260984 @default.
- Q66036902 P4844 Q412415 @default.
- Q66036902 P580 "2001-06-01T00:00:00Z" @default.
- Q66036902 P582 "2007-02-01T00:00:00Z" @default.
- Q66036902 P6099 Q42824827 @default.
- Q66036902 P8363 Q78089383 @default.